Herpes zoster in the older adult
Date Published:
Tuesday, April 5, 2022
Duration:
22:50
Tyson Oberndorfer talks about Herpes zoster (or shingles) in older adults, and how GPs play a crucial role in its management.
Topics:
- 00:01 Intro
- 01:05 Why is HZ more a disease of older people?
- 01:45 Reactivation of the varicella virus
- 02:39 At what age does our immune system start to falter?
- 03:24 What factors impact the immunosenescence or the risk of HZ?
- 04:33 Modifiable environmental or behavioural factors
- 05:19 Vaccines
- 05:58 What is Shingrix?
- 06:58 How does that efficacy compare with Zostavax?
- 08:44 Follow up period of 3-4 years. Do we know how well these vaccines perform beyond that?
- 10:10 Are there any people you wouldn’t offer vaccination?
- 11:46 Vaccine effectiveness
- 13:29 is first episode less severe in those who are vaccinated?
- 14:06 Treatment approach with persistent PHN
- 15:48 Stepwise approach to oral methods
- 20:31 Is there a role for vaccination post episode?
- 20:57 Take-home messages
Take-home messages
|
Resources
- SHINGRIX data sheet Medsafe
- ZOSTAVAX data sheet Medsafe
- What is herpes zoster? Dermnet NZ
- Herpes zoster (shingles) IMAC
Presenter
Tyson Oberndorfer
Consultant Geriatrician
Tyson Oberndorfer is a Consultant Geriatrician at Taranaki District Health Board. He is medical co-director of the Frailty Initiative, which aims to develop a pathway of care for older people with frailty as they move through the healthcare system. Prior to moving to NZ, he held an Assistant Professor position at the University of Colorado and was the co-founder and medical director of the UCHealth Fall Prevention Clinic.
This episode is supported by an educational grant from GSK.
This presentation is intended for qualified health practitioners professional development and should not be relied upon for any other purpose. Any opinions offered are those of the presenter or other speaker and do not necessarily represent the views of Goodfellow Unit.